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Abstract
Background: Default from multidrug-resistant tuberculosis (MDR-TB) treatment remains a major barrier to cure and
epidemic control. We sought to identify patient risk factors for default from MDR-TB treatment and high-risk time
periods for default in relation to hospitalization and transition to outpatient care.
Methods:  We  retrospectively  analyzed  a  cohort  of  225  patients  who  initiated  MDR-TB  treatment  between  2007
through 2010 at a rural TB hospital in the Western Cape Province, South Africa.
Results: Fifty percent of patients were cured or completed treatment, 27% defaulted, 14% died, 4% failed treatment,
and 5% transferred out. Recent alcohol use was common (63% of patients). In multivariable proportional hazards
regression, older age (hazard ratio [HR]= 0.97 [95% confidence interval 0.94-0.99] per year of greater age), formal
housing (HR=0.38 [0.19-0.78]), and steady employment (HR=0.41 [0.19-0.90]) were associated with decreased risk
of default, while recent alcohol use (HR=2.1 [1.1-4.0]), recent drug use (HR=2.0 [1.0-3.6]), and Coloured (mixed
ancestry) ethnicity (HR=2.3 [1.1-5.0]) were associated with increased risk of default (P<0.05). Defaults occurred
throughout the first 18 months of the two-year treatment course but were especially frequent among alcohol users
after  discharge  from  the  initial  four-to-five-month  in-hospital  phase  of  treatment,  with  the  highest  default  rates
occurring  among  alcohol  users  within  two  months  of  discharge.  Default  rates  during  the  first  two  months  after
discharge were also elevated for patients who received care from mobile clinics.
Conclusions: Among patients who were not cured or did not complete MDR-TB treatment, the majority defaulted
from treatment. Younger, economically-unstable patients and alcohol and drug users were particularly at risk. For
alcohol users as well as mobile-clinic patients, the early outpatient treatment phase is a high-risk period for default
that could be targeted in efforts to increase treatment completion rates.
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Globally  and  in  South  Africa,  the  proportion  of  multidrug-
resistant  tuberculosis  (MDR-TB)  patients  who  successfully
complete treatment remains less than 50% [1,2]. Completion of
MDR-TB  treatment  is  challenging  due  to  its  long  duration
(18-24 months), high pill burden, requirement of injections, and
frequent side effects, leading many patients to default, defined
as stopping regular treatment for two months or more prior to
completing their treatment course. Default rates greater than
20%  have  been  reported  in  South  Africa  [3,4].  The  resulting
incomplete treatment is associated with high patient mortality
[5,6] and increasingly-resistant TB strains [7].
Identified  risk  factors  for  default  from  treatment  of  drug-
sensitive  (DS)  TB  include  alcoholism  and  other  substance
abuse,  low  socioeconomic  indicators,  and  health  systems
factors  such  as  inadequate  patient  education  and  difficult-to-
access care [8–10]. MDR-TB differs from DS-TB, however, with
regard to both the prior treatment experience of the patients
[11]  and  the  increased  difficulty  and  longer  duration  of  the
treatment  regimen.  Risk  factors  for  default  among  patients
treated  for  MDR-TB,  particularly  socioeconomic  and
substance-abuse  risk  factors  and  risk  factors  in  rural
communities, are incompletely characterized.
Because of the required injections and the high pill burden,
MDR-TB  treatment  is  commonly  initiated  in  the  inpatient
setting. Once patients are stabilized and have sputum that is
smear-negative for Mycobacterium tuberculosis, and often after
injectable medications are completed, patients are transitioned
to  the  outpatient  setting  to  complete  more  than  a  year  of
additional  therapy.  The  inpatient  and  ambulatory  settings
create  different  sets  of  obstacles  for  patient  adherence:
ambulatory  treatment  disrupts  patients’  lives  less  than
hospitalization,  but  it  requires  their  active  participation  and
exposes them to competing pressures of family, livelihood, and
substance use [12]. Additionally, the transition from inpatient to
outpatient treatment may be a time of increased risk of loss to
follow up, as has been observed for DS-TB in Moldova [13]. In
this study, we sought to identify baseline risk factors for default
from  MDR-TB  treatment  and  determine  when  during  the
treatment  course  default  is  most  likely  to  occur,  with  special
attention  to  the  transition  period  between  inpatient  and
outpatient treatment settings.
Methods
Ethics Statement
The  study  protocol  was  approved  by  the  Health  Research
Ethics  Committee,  Stellenbosch  University,  the  Institutional
Review Board of Boston University Medical Campus, and the
Office of Human Research Administration, Harvard School of
Public  Health  (exemption  granted  of  additional  review).  The
approving IRBs specifically waived the requirement of patient
consent for information from their clinical records to be placed
into a de-identified research database.
Study Population
We  conducted  a  retrospective  cohort  study  of  all  adult
patients (age > 15 years) who initiated MDR-TB treatment at
Brewelskloof  Hospital  (BKH),  the  TB  referral  hospital  for  the
Cape  Winelands  East  and  Overberg  districts,  Western  Cape
Province,  South  Africa,  between  1  January  2007  and  31
December  2010.  BKH  serves  a  largely  rural,  agricultural
population of approximately 600,000 people, and TB is one of
the top three causes of death in all the region’s subdistricts,
with 6714 cases of TB in 2008 and 74 cases of MDR-TB in
2008-09  [14].  Patients  diagnosed  with  MDR-TB  at  general
hospitals,  local  clinics,  or  mobile  clinics  in  this  region  were
referred to BKH to initiate treatment. MDR-TB was defined as
infection with disease caused by  M. tuberculosis resistant to
both isoniazid and rifampin, as determined by culture-based or
molecular-based  (Genotype  MTBDRplus  line  probe  assay)
susceptibility testing.
At  BKH,  standard  care  for  MDR-TB  patients  included
hospitalization for the first four to five months of a 24-month
treatment  course.  While  in  hospital,  patients  without
contraindication  to  aminoglycosides  received  kanamycin
injections,  in  addition  to  oral  therapy  of  pyrazinamide,
ethionamide,  ofloxacin,  and  either  ethambutol  or  terizadone.
Patients remained in hospital until their sputum was smear and
culture  negative  for  two  consecutive  months,  typically  for  a
minimum of four months, although some early discharges were
arranged  for  personal  or  disciplinary  reasons.  Patients  then
continued oral treatment as outpatients, typically at the health
clinics where they were diagnosed. Depending on the distance
between  patients'  homes  and  clinic,  patients  either  went  to
clinic  daily  for  directly-observed  therapy  (DOT),  received
medications every one to two weeks at clinic with community
workers  visiting  their  homes  between  clinic  visits  for  home-
based  DOT,  or,  if  they  were  particularly  far  from  a  clinic,
received medications monthly from a mobile clinic and were not
routinely linked to a community health worker. Care at clinics
was carried out by nurses and supervised by BKH doctors who
visited monthly.
Data collection
Both  hospital  and  outpatient  clinic  records  for  all  MDR-TB
patients  were  maintained  in  a  central  office  at  BKH.  BKH
doctors collected social and economic variables on admission
as  part  of  their  standard  patient-history  template.  We
abstracted hospital and clinic records in a de-identified manner
using a standardized form for the following baseline variables:
patient  age,  gender,  race,  height,  and  weight;  human
immunodeficiency  virus  (HIV)  status,  CD4  count,  and
antiretroviral therapy (ART) use; comorbid psychiatric disease
and diabetes mellitus; recent alcohol, tobacco, and illicit drug
use;  marital  status;  employment  status  and  type  of
employment; location of residence (in town versus on a farm),
type of housing, and presence of electricity, running water, and
toilet  in  the  home;  prior  TB  history  including  outcomes  of
previous  treatment;  and  patients'  current  MDR-TB  status
including  sputum  collection  dates  and  results,  site(s)  of
disease, the clinic making the MDR-TB diagnosis and referral,
dates of hospital admission and discharge, treatment regimens
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Subsequent,  post-baseline  measurements  of  these  variables
were not recorded. Employment was classified as “steady” if
the  patient  was  employed  in  a  year-round  (as  opposed  to  a
seasonal  or  day-labor)  position  or  was  a  full-time  student.
Housing  was  classified  as  formal  (a  building  of  durable
materials at an official address) or informal (a shack or shanty
in a backyard or informal settlement), as the terms are used in
South African housing surveys [15]. Alcohol, drug, and tobacco
use were positive if there was recent use as recorded by the
physician at intake.
Outcomes were classified according to standard definitions
[16]:  cure  or  treatment  completion  required  completion  of
prescribed therapy with or without microbiological confirmation
of cure, respectively; default occurred if a patient missed two
consecutive months of therapy for any reason, and was dated
from the first day of the treatment interruption; outcome was
death if a patient died of any cause while receiving MDR-TB
treatment; failure occurred if a patient had persistently-positive
culture  results  late  in  treatment,  or  if  treatment  was  stopped
early due to poor response or second-line drug resistance; and
final  outcome  was  transfer  if  a  patient  moved  to  another
reporting and recording unit and the outcome of treatment was
unknown.
Statistical Methods
We  compared  baseline  patient  characteristics  between
outcome groups, grouping cure with treatment completion and
grouping death with failure in order to focus on default (Table
1). Age, body mass index, CD4 count, years of schooling, and
time  from  sputum  collection  to  treatment  initiation  were
analyzed  as  continuous  variables,  and  other  variables  were
categorical.
We then examined baseline risk factors for time to default in
univariable  and  multivariable  Cox  proportional  hazard
Table 1. Baseline characteristics of MDR-TB patients initiating treatment at Brewelskloof Hospital 2007-2010, overall and
stratified by outcome category.
Variable All outcomes N
a Outcome category
b
P
c
     
Cure or Treatment
Completion(N=113
d
) Default(N=61
d
)Death or Failure(N=43
d
) 
Age (years, mean ± SD) 37.5± 11.9 225 38.1 ± 12.2 34.7 ± 10.5 40.7 ± 12.5 0.03
Female (N (%)) 98 (44%) 225 54 (48%) 25 (41%) 17 (40%) 0.54
Coloured (N (%)) 174 (77%) 225 87 (77%) 52 (85%) 31 (72%) 0.24
Married (N (%)) 56 (26%) 219 37 (34%) 9 (15%) 8 (20%) 0.02
Formal dwelling (N (%)) 154 (77%) 199 90 (88%) 35 (69%) 27 (69%) 0.004
Water, toilet, and electricity in dwelling (N (%)) 116 (73%) 160 68 (80%) 26 (67%) 21 (62%) 0.08
Town (non-farm) address (N (%)) 154 (69%) 223 81 (72%) 35 (58%) 33 (77%) 0.09
Diagnosed at mobile clinic (N (%)) 19 (8%) 224 10 (9%) 9 (15%) 1 (2%) 0.10
Education (years, median (Q1, Q3)) 7 (4, 10) 203 8 (5, 10) 7 (4, 9) 7 (4, 9) 0.23
Employed (N (%)) 135 (64%) 212 69 (66%) 37 (62%) 26 (63%) 0.83
Steady employment (non-seasonal job, or student) (N (%)) 51 (24%) 212 32 (31%) 7 (12%) 11 (27%) 0.02
Recent alcohol use (N (%)) 134 (63%) 214 57 (54%) 47 (78%) 27 (63%) 0.01
Recent tobacco use (N (%)) 157 (73%) 215 72 (67%) 50 (85%) 32 (74%) 0.05
Recent illicit drug use (N (%)) 26 (13%) 203 7 (7%) 14 (25%) 4 (10%) 0.005
Current is first known TB episode (N (%)) 30 (13%) 225 15 (13%) 7 (11%) 4 (9%) 0.78
Prior default from TB treatment (N (%)) 49 (22%) 225 21 (19%) 18 (30%) 8 (19%) 0.21
Initial sputum smear AFB positive (N (%)) 87 (43%) 204 45 (42%) 23 (46%) 16 (39%) 0.80
Extrapulmonary TB disease (N (%)) 25 (11%) 220 9 (8%) 2 (3%) 12 (29%) <.001
BMI (m2/kg) 18.8 ± 3.8 184 19.2 ± 4.2 18.4 ± 3.0 18.0 ± 3.7 0.21
HIV positive (N (%)) 70 (32%) 222 30 (27%) 12 (20%) 24 (56%) <.001
CD4 count 141 (57, 273) 66/70 219 (88, 296) 199 (98, 489) 69 (39, 116) 0.01
On ARVs at MDR-TB treatment initiation (N (% of HIV
infected))
13 (19%) 70/70 8 (27%) 1 (8%) 3 (7%) 0.25
Diabetes mellitus at baseline (N (%)) 8 (4%) 223 6 (5%) 1 (2%) 0 (0%) 0.17
Psychiatric comorbidity (N (%)) 7 (3%) 225 5 (4%) 1 (2%) 1 (2%) 0.57
Days from sputum collection to MDR treatment initiation 65 (42, 94) 224 68 (51, 92) 67 (41, 117) 55 (32, 78) 0.07
a Total number of patients with available (non-missing) data for variable
b Transferred patients are excluded from this analysis.
c P value is calculated for three-way comparison between “cure or treatment completion”, “default”, and “death or failure” groups, using ANOVA, Kruskal-Wallis rank sum, or
Pearson’s Chi-square tests as appropriate.
d Some values were missing for some variables.
doi: 10.1371/journal.pone.0083480.t001
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MDR treatment. Defaults were modeled as events, and other
final outcomes were censored when they occurred. We verified
proportional  hazards  assumptions  by  confirming  that
interactions  between  each  covariate  and  time  on  treatment
were  not  statistically  significant,  and  by  visual  inspection  of
graphs of log(-log(survival)) versus log(time) stratified by each
categorical  variable.  To  generate  a  multivariable  proportional
hazards regression model for time to default, we considered all
variables  that  were  associated  with  default  at  P  <  0.2  in
univariate  analysis,  and  we  retained  variables  that  were
associated  with  default  at  P  <  0.1  when  added  to  the
multivariate model. To account for missing data, we performed
regression  analyses  using  fivefold  multiply-imputed  datasets
generated  by  Markov  chain  Monte  Carlo  methods  (SAS  MI
procedure; SAS Institute), then pooled effect estimates across
datasets [17].
To examine how the default rate changed over time and how
the relationship between default and risk factors varied during
treatment, we calculated default rates for three time periods:
during  hospitalization,  within  two  months  of  discharge  (“the
early outpatient period”), and from two months after discharge
until termination of treatment (“the late outpatient period”). We
calculated  these  default  rates  for  all  patients  and  also  when
stratified by variables which we hypothesized would negatively
impact treatment adherence in the outpatient setting: baseline
recent alcohol use, whether the MDR-TB diagnosis was made
in  a  stationary  or  mobile  clinic,  and  whether  the  patient’s
primary  address  was  in  town  (indicating  proximity  to  a  local
health  clinic)  versus  a  farm  address  (indicating  a  longer
distance from routine TB care). We used tests of homogeneity
to examine whether the associations between these risk factors
and  default  differed  by  different  treatment  time  periods  (i.e.,
during hospitalization, the early outpatient period, and the late
outpatient period).
We performed all statistical analyses using SAS version 9.3.
Results
MDR-TB patient characteristics
We identified 225 MDR-TB patients who started treatment for
MDR-TB at BKH between 1 January 2007 and 31 December
2010.  MDR-TB  was  confirmed  by  culture  or  molecular
resistance  testing  in  223  patients;  two  additional  patients
received empiric treatment based on previous culture history.
Thirty-two percent of patients had HIV co-infection (Table 1).
Thirty-six  percent  were  unemployed  at  time  of  MDR-TB
treatment enrollment, 24% had steady employment, and 40%
worked  seasonally  or  as  day-laborers.  Sixty-three  percent  of
patients reported recent alcohol use, and 13% reported recent
use  of  illicit  drugs,  typically  marijuana  or  mandrax  (the
sedative-hypnotic  methaqualone,  mixed  with  marijuana  and
smoked). Eighty-three percent of patients had previously been
treated  for  DS  or  DR  TB,  and  22%  were  known  to  have
previously defaulted from TB treatment. Seventy-seven percent
of patients were of Coloured (mixed ancestry) ethnicity, 22%
were  Black  African,  and  two  patients  were  White.  Black
patients  were  more  likely  than  Coloured  patients  to  be  HIV
infected (67% versus 22%) and live in informal housing (44%
versus 17%); they were less likely than Coloured patients to
use alcohol (41% versus 68%) or tobacco (44% versus 81%)
(all p<0.01).
Treatment outcomes and associated characteristics
Half  of  patients  were  either  cured  (86  patients,  38%)  or
completed  treatment  (27  patients,  12%).  Sixty-one  patients
(27%)  defaulted,  32  (14%)  died  during  treatment,  11  (5%)
failed treatment, and 8 (4%) transferred out. Comparisons of
baseline characteristics between outcome groups are shown in
Table 1.
With monthly sputum monitoring, 203 patients converted to
negative sputum culture on treatment, and the mean time to
first  culture-negative  sputum  was  60  ±  47  days.  Among  the
patients who defaulted, the sputum of fifty-four patients (89%)
tested  negative  by  culture  before  default,  four  patients  (7%)
remained positive by culture throughout MDR treatment for a
median of 5 months (range 1 to 10 months) prior to defaulting,
and  three  patients  (5%)  defaulted  early  before  a  second
sputum was collected.
Risk factors for default
Univariate risk factors for default included alcohol, tobacco,
and  illicit  drug  use,  younger  age,  unmarried  status,  lack  of
steady  employment,  informal  dwelling,  rural  address,  and
diagnosis  of  MDR-TB  at  a  mobile  clinic  (Table  2).  In
multivariable  analysis,  recent  alcohol  use  (hazard  ratio
(HR)=2.1 [95% CI 1.1-4.0], P=0.02), recent drug use (HR=2.0
[1.0-3.6],  P=0.03),  and  Coloured  ethnicity  (HR=2.3  [1.1-5.0],
P=0.04)  were  risk  factors  for  default,  while  formal  housing
(HR=0.38 [0.19-0.78], P=0.01), steady employment (HR=0.41
[0.19-0.90], P=0.03), and older age (HR=0.97 [0.94-0.99] per
year of greater age, P=0.01), were associated with a lower rate
of default (Table 2).
Drug,  alcohol,  and  tobacco  use  were  intercorrelated  (all
associated pairwise with P<0.001), but alcohol use and drug
use were independently associated with default. Although we
found  no  statistically  significant  interaction  between  any
covariate and time on treatment, visual inspection of graphs of
the  log(-log(survival))  versus  log(time)  suggested  possible
violations  of  the  proportional  hazards  assumption  for  alcohol
use as well as for MDR-TB diagnosis at a mobile clinic.
Timing of default
Patients  with  outcomes  of  cure  or  treatment  completion
received median 739 (IQR 714-768) total days of treatment and
were  discharged  from  the  hospital  after  median  127  (IQR
117-175)  days.  For  patients  who  defaulted,  median  time  to
default was 257 days (interquartile range (IQR) 126-363 days).
Of the 61 patients who defaulted, 15 (25%) defaulted during
hospitalization–for example, by refusing further treatment or by
failing to return from weekend leave. The default rate increased
after  discharge,  and  patients  defaulted  during  the  early
outpatient period at 1.7 times the overall average default rate,
although  as  discussed  further  below,  no  increased  rate  of
default after discharge was seen in patients who had denied
Risk Factors for MDR-TB Treatment Default
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the eighteenth month of treatment.
Effect modifiers of post-discharge default risk
The relative risk of default associated with alcohol use varied
with  the  hospitalization  status  (P=0.07  for  test  for
homogeneity). During the in-hospital period, default rates were
comparable  among  those  who  did  and  did  not  report  recent
alcohol  use,  but  those  with  recent  reported  use  at  baseline
defaulted nearly four times as frequently as nonusers during
the  early  outpatient  period  and  continued  to  default  more
frequently  than  nonusers  during  the  late  outpatient  period
(Figure 1). Among patients who did not report recent alcohol
use, the default rate declined after the initial, in-hospital period.
Table  2.  Single-  and  multivariable  proportional-hazard
regression models of default from MDR-TB treatment.
Baseline variable
Hazard ratio (95%
CI) in univariate
analysis P
Hazard ratio (95%
CI) in
multivariable
model P
Recent illicit drug use 2.78 (1.48, 5.22) 0.001 2.02 (1.04, 3.95) 0.04
Recent alcohol use 2.24 (1.22, 4.13) 0.01 2.11 (1.11, 4.02) 0.02
Steady employment (non-
seasonal job, or student)
0.37 (0.17, 0.80) 0.01 0.41 (0.19, 0.90) 0.03
Married 0.42 (0.21, 0.84) 0.01    
Formal dwelling 0.48 (0.25, 0.91) 0.03 0.38 (0.19, 0.78) 0.01
Age, per year of older age 0.98 ( 0.96, 1.00) 0.05 0.97 (0.94, 0.99) 0.01
Diagnosed at mobile clinic 2.00 (0.99, 4.07) 0.05    
Recent tobacco use 2.02 (1.01, 4.05) 0.05    
Town (non-farm) address 0.61 (0.37, 1.02) 0.06    
Prior default from TB
treatment
1.66 (0.95, 2.87) 0.07    
BMI (per m2/kg) 0.94 (0.87, 1.01) 0.11    
HIV infected 0.61 (0.32, 1.14) 0.12    
Coloured ethnicity 1.72 (0.85, 3.49) 0.13 2.24 (1.03, 4.87) 0.04
Water, toilet, and electricity
in patient’s dwelling
0.63 (0.33, 1.20) 0.17    
Education (per year of
schooling)
0.97 (0.90, 1.03) 0.30    
Diabetes mellitus 0.36 (0.05, 2.69) 0.31    
Female 0.82 (0.49, 1.36) 0.44    
Initial sputum smear AFB
positive at time of MDR-TB
diagnosis
1.15 (0.67, 2.01) 0.60    
Number of prior TB
episodes (per prior
episode)
0.94 (0.72, 1.22) 0.64    
Current MDR-TB episode
is patient’s first known TB
episode
0.89 (0.40, 1.95) 0.76    
Employed (any
employment)
0.95 (0.55, 1.62) 0.84    
doi: 10.1371/journal.pone.0083480.t002
We also investigated whether patients with a farm address
(versus  a  town  address)  or  those  who  were  diagnosed  with
MDR-TB  at  a  mobile  clinic  (versus  a  hospital  or  local  clinic)
experienced  higher  rates  of  default  after  hospital  discharge,
since these patients may have more difficulty accessing care
due  to  longer  distances  to  health  facilities  and  often  do  not
receive daily DOT. In the early outpatient period, patients who
had  been  diagnosed  at  mobile  clinics  defaulted  at  a  seven
times  greater  rate  than  other  patients.  This  higher  rate  of
default was confined to the early outpatient period (P=0.08 for
test of homogeneity). We did not find any association between
reporting recent alcohol use and being diagnosed at a mobile
clinic (Pearson’s Chi-square P=0.58). Although having a farm
address  was  associated  with  default  in  univariable  analysis
(Table 1), we did not detect effect modification by time relative
to hospital discharge (P=0.41 for test of homogeneity).
Discussion
In our rural South African MDR-TB cohort, 27% of patients
defaulted  from  treatment  before  completing  a  full  24-month
course ‒ twice the 12-15% average default rate in published
MDR-TB cohorts worldwide [18–20]. The high default rate we
observed  remains  comparable  to  previously-observed  South
African  MDR-TB  treatment  default  rates  of  29%  in  an  urban
Western Cape TB hospital in 1992-2002 [21] and of 21% in
high-HIV-prevalence regions in 2000-2004 prior to antiretroviral
availability  [3,4].  Even  if  MDR-TB  mortality  and  treatment
failure  decline  with  improved  diagnostics,  drugs,  and  other
medical care, the 2015 target treatment success rate of 75%
will remain unattainable unless these high rates of default also
improve  [1].  Recent  South  African  MDR-TB  guidelines
recommend post-hoc interventions (psychological evaluations,
substance abuse rehabilitation programs, or transportation or
food aid) for patients who have demonstrated poor treatment
compliance  for  corresponding  reasons  [22],  but  it  would  be
preferable  to  allocate  these  resources  effectively  before
defaults occur. Our findings demonstrate that certain socially-
unstable patients are at risk for default and could benefit from
adherence-focused interventions throughout their treatment. In
addition,  the  association  we  found  between  alcohol  use  and
post-discharge  default  highlights  a  patient  population  at
particular  risk  as  MDR-TB  treatment  delivery  moves
increasingly to the outpatient setting.
Alcohol is known to be associated with developing active TB,
as  well  as  with  poor  clinical  outcomes  including  drug
resistance.  Alcohol  is  also  associated  with  default  from
treatment  of  DS  TB,  likely  because  of  social  destabilization
caused by alcoholism, but possibly also in part because alcohol
magnifies  medication  toxicities  [23].  The  few  other  MDR-TB
cohorts  to  report  substance  use  data  have  also  noted
substance  use  as  a  risk  factor  for  treatment  default:  alcohol
abuse  was  a  risk  factor  in  Eastern  Europe  [24,25],  and
substance (drug and/or alcohol) use was a risk factor in Peru
and  South  Africa  [6,26].  Our  findings  go  further  in
demonstrating that a history of alcohol use may be especially
predictive of default during the outpatient portion of treatment.
We  also  show  alcohol  and  drug  use  to  be  independent  risk
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variables. Alcohol use is prevalent in the Western Cape [27],
and hospital-enforced abstinence may enhance initial treatment
retention  among  alcohol  users.  Patients  who  use  alcohol
should be followed closely during the transition from hospital to
outpatient  treatment  to  ensure  that  they  establish  care  with
local clinics. Although financial supports such as free food and
transportation  reimbursement  alone  may  not  increase
adherence in alcoholics [25], integrating medical or behavioral
treatment  of  alcoholism  into  TB  care  has  been  shown  to
improve treatment adherence for some alcohol-using patients
[28]. Drug use, although less common than alcohol use in our
study population, may increase default by similar mechanisms
and may be amenable to similar interventions.
The  association  we  found  between  informal  housing  and
default  agrees  with  previous  identification  of  substandard
housing conditions in Peru [6] and unstable residence in a five-
province South African sample [26] as risk factors for MDR-TB
treatment  default  –  although  the  Peruvian  study,  which
provided extensive social, financial, and psychiatric supports,
had a much lower overall default rate of 10% [6]. In addition,
we  found  that  patients  without  steady  employment,  many  of
whom are seasonal farm workers in our study setting, are also
at risk. To retain younger patients and patients with competing
basic socioeconomic needs in care for the duration of MDR-TB
treatment,  targeted  interventions  to  consider  include
community  health  worker  support,  DOT,  and  comprehensive
financial  support  packages,  all  of  which  have  demonstrated
effectiveness [18].
We  did  not  find  associations  between  default  and  HIV  or
prior  TB  treatment.  Although  HIV  was  previously  noted  as  a
risk  factor  for  default  in  South  Africa  prior  to  widespread
antiretroviral treatment [3], HIV was associated with death but
not  default  in  our  cohort,  perhaps  because  many  of  these
patients are also connected to the public health system for HIV
as  well  as  TB  care.  Prior  default  has  been  predictive  of
repeated default from DS-TB treatment [9,29], and although we
saw some evidence of a similar trend in MDR-TB patients, the
association  was  not  significant  in  multivariable  analysis  and
appears to be largely accounted for by other measurable risk
factors such as substance use and employment status.
The elevated default rates we observed in the two months
immediately  after  discharge  highlight  the  transition  period
between the inpatient and outpatient treatment settings as a
high-risk time for MDR-TB treatment adherence. The increased
rate of default in that period appears to be driven by individuals
with a history of recent alcohol use. Also, although the sample
size  of  patients  using  mobile  clinics  was  small,  having  been
diagnosed at a mobile clinic was also associated with a greater
risk  of  default  in  the  early  outpatient  period,  and  this
association  did  not  appear  to  be  explained  by  alcohol  use.
South African guidelines recommend but do not require DOT
Figure 1.  Default rates for patients on MDR-TB treatment, by time period and alcohol use status.  Default rates with 95%
confidence intervals were calculated in each of three time periods defined relative to hospital discharge date. Rates are shown for
all patients as well as stratified by reported history of recent alcohol use.
doi: 10.1371/journal.pone.0083480.g001
Risk Factors for MDR-TB Treatment Default
PLOS ONE | www.plosone.org 6 December 2013 | Volume 8 | Issue 12 | e83480beyond the intensive phase of therapy [22], and at the time of
this  study,  most  patients  treated  by  mobile  clinics  did  not
receive  daily  DOT,  which  could  facilitate  the  transition  to
outpatient care. Although high default rates following discharge
have  not  been  previously  described  for  MDR-TB,  a  similar
increase in default rates after discharge from the in-hospital,
intensive treatment phase was reported among DS-TB patients
in Moldova[13].
We note limitations to this study. Drug, tobacco, and alcohol
use at intake were available for nearly all patients, but use was
not quantified nor re-evaluated later during care. Quantification
could help identify a threshold at which alcohol and drug use
are problematic for adherence. It is known that drinking in this
region  tends  to  involve  binging  rather  than  moderate  social
use, and therefore, reported alcohol use often indicates abuse.
In  one  survey  of  farm  workers  in  the  region,  87%  screened
positive for problem drinking by the CAGE questionnaire [27].
Women drink heavily as well; in a household survey, 68% of
women who drank were classified as high-risk drinkers by the
Alcohol Use Disorders Identification Test (AUDIT) scale [30].
Had we been able to distinguish between high-risk and more
moderate  alcohol  use,  we  may  have  observed  a  stronger
association between high-risk alcohol use and default than that
which we observed for any recent alcohol use.
We  were  unable  to  enroll  or  quantify  those  patients
diagnosed  with  MDR-TB  who  never  started  treatment.  Only
44% of the South African patients who were diagnosed with
MDR-TB in 2011 initiated treatment [31], and the risk factors for
never entering care may differ from the risk factors for starting
but  not  completing  treatment.  We  also  cannot  determine
whether associations we observed were causal, although these
associations  are  mechanistically  plausible.  Lastly,  we  had
limited information about patients’ access to clinics; we used
farm  addresses  and  mobile  clinic  diagnoses  as  proxies  for
longer distances to clinic. Precise travel times to clinic and data
about frequency of health worker contact would help clarify the
extent to which proximity to health clinics affects default.
Default is a major barrier to cure in MDR-TB patients, and in
this rural farming population, younger patients, economically-
unstable patients, patients receiving care from mobile clinics,
and alcohol and drug users are particularly at risk for default.
Socioeconomic supports targeting the most at-risk groups may
help to increase treatment adherence in the Western Cape and
similar areas of high MDR-TB burden. Also, although outpatient
treatment  may  be  easier,  more  affordable,  and  better  for
patients  in  the  long  run,  the  transition  from  in-hospital  to
community-based treatment is a difficult period in which extra
care  must  be  taken  to  prevent  default.  Because  of  alcohol-
using patients’ higher default rate during the transition period
and in the outpatient setting, MDR-TB programs should assess
alcohol use patterns in their patient populations and consider
following  and  supporting  alcohol-using  patients  more
intensively.
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